OGI.V - OrganiGram Holdings Inc.

TSXV - TSXV Delayed Price. Currency in CAD
4.62
+0.17 (+3.82%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close4.45
Open4.40
Bid4.56 x 0
Ask4.65 x 0
Day's Range4.36 - 4.65
52 Week Range2.11 - 5.93
Volume238,718
Avg. Volume755,314
Market Cap575.989M
Beta5.95
PE Ratio (TTM)N/A
EPS (TTM)-0.04
Earnings DateJul 27, 2017 - Jul 28, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.82
  • ACCESSWIRE11 days ago

    Today's Research Reports on Emblem, OrganiGram, Oncolytics Biotech and Aptose Biosciences

    NEW YORK, NY / ACCESSWIRE / July 11, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...

  • Baystreet12 days ago

    Stocks in play: Organigram Holdings Inc.

    Has entered into a letter of intent with Hiku Brands Company Ltd. Organigram Holdings Inc. shares V.OGI ...

  • CNW Group12 days ago

    Organigram Signs Strategic Supplier Agreement with Hiku Brands

    Agreement brings up to 1,000kg of Organigram's premium indoor-grown cannabis products to Tokyo Smoke, Hiku's licensed chain of cannabis stores in Manitoba MONCTON, NB , July 10, 2018 /CNW/ - Organigram ...

  • CNW Group17 days ago

    Organigram signs supply agreement with the Alberta Gaming, Liquor & Cannabis Commission (AGLC)

    MONCTON, NB, July 5, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF - News), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading  licensed producer of medical marijuana, is pleased to announce that the Company has signed a supply agreement with the Alberta Gaming, Liquor & Cannabis Commission (AGLC) in anticipation of the launch of a legal, adult use recreational cannabis market in the Province of Alberta.

  • Baystreet23 days ago

    Stocks in play: Organigram Inc.

    Said its Organigram Holdings Inc. division has been approved as a supplier of cannabis for the province ...

  • CNW Group23 days ago

    Organigram signs supply agreement with Manitoba Liquor & Lotteries

    MONCTON, NB, June 29, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQB:OGRMF - News), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, is pleased to announce that it has been approved as a supplier of cannabis for the province of Manitoba. "We are proud to work with MBLL to offer residents of Manitoba a choice of high-quality cannabis products," says Tim Emberg, Organigram Vice President of Sales and Commercial Operations.

  • Cannabis in Canada: An inside look at Canada's marijuana industry
    Yahoo Finance Canadalast month

    Cannabis in Canada: An inside look at Canada's marijuana industry

    With recreational marijuana set to become legal in mid-October, we wanted to hear from those with a direct stake in the game. Yahoo Canada Finance sat down with Canopy Growth CEO Bruce Linton, Organigram CEO Greg Engel, and Motley Fool Canada journalist Iain Butler to find out how these companies are preparing for legalization, and what investors need to know if they plan on putting their money into this rapidly expanding industry.

  • CNW Grouplast month

    Orgranigram applauds Senate vote in support of Bill C-45

    MONCTON, NB, June 8, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF - News) (the "Company" or "Organigram"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, is pleased that Bill C-45 has been passed by the Senate in a historic vote, clearing another key milestone on the way to the legalization of adult-use recreational cannabis in Canada. "As a company, we are pleased to see Bill C-45 continue to make its way through the regulatory process," says Greg Engel, CEO, Organigram.

  • Baystreet2 months ago

    Stocks in play: Organigram Holdings Inc.

    Has received an expanded cultivation license from Health Canada related to its previously announced ...

  • CNW Group2 months ago

    Organigram Announces Health Canada Licensing of Phase 3 Cultivation Expansion

    TORONTO, June 5, 2018 /CNW/ - Organigram Holdings Inc. ("Organigram" or the "Company") (TSX VENTURE: OGI) (OTCQB:OGRMF - News) a leading licensed producer of medical marijuana based in Moncton, New Brunswick, is pleased to announce that it has received an expanded cultivation license from Health Canada related to its previously announced Phase 3 expansion. The remaining ten Phase 3 rooms are expected to come online on or before June 30, 2018 in stages pending Health Canada approval.

  • FSCWire2 months ago

    Organigram Enters into Non-Binding Term Sheet for 26% Equity Interest in Eviana Health Corporation

    Organigram Holdings Inc. (“Organigram”) (TSX VENTURE: OGI) (OTCQB: OGRMF) and Eviana Health Corporation (“Eviana”) (CSE: EHC) (OTC: EVNNF) (collectively the “Companies”) are pleased to jointly announce that the Companies have entered into a non-binding term sheet (the “Term Sheet”) whereby Organigram will make a significant equity investment into Eviana.  Additionally, the Term Sheet contemplates Organigram entering into an offtake agreement with Eviana for up to 50% of the cannabidiol (“CBD”) production of Eviana for a period of five years, subject to adjustment based on Organigram’s equity interest in Eviana. “This agreement is a key facet of our ongoing international expansion efforts,” explains Greg Engel, CEO, Organigram.

  • ACCESSWIRE2 months ago

    Today's Research Reports on Centric Health, Emblem, OrganiGram and Acerus Pharmaceuticals

    NEW YORK, NY / ACCESSWIRE / June 4, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with ...

  • CNW Group2 months ago

    Organigram Announces Letter of Intent for Strategic Investment in Hyasynth Biologicals Inc.

    MONCTON, NB, May 24, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQB:OGRMF - News) ("Organigram"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, is pleased to announce that it has entered into a letter of intent with Hyasynth Biologicals, Inc. ("Hyasynth") whereby Organigram proposes to make a strategic investment in Hyasynth.  Additionally, the non-binding letter of intent contemplates Organigram entering into an off-take agreement with Hyasynth whereby Organigram can purchase a pre-defined quantity of a range of cannabinoids or cannabinoid related production from Hyasynth on terms set forth in such agreement.

  • CNW Group2 months ago

    Organigram Receives Permit to Export Medical Cannabis to Australia

    Company Continues to Build International Presence Leveraging Award-Winning, High-Quality Product MONCTON, NB , May 17, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF) (the " ...

  • Organigram Unveils Comprehensive Suite of Adult Recreational Cannabis Brands
    CNW Group2 months ago

    Organigram Unveils Comprehensive Suite of Adult Recreational Cannabis Brands

    Organigram's unprecedented recreational portfolio will be officially launched once adult use recreational cannabis is legal in Canada and includes the launch of The Edison Cannabis Company, ANKR Organics and Trailer Park Buds.

  • CNW Group2 months ago

    Organigram Announces Receipt of License for Controlled Drugs and Substances from Health Canada

    MONCTON, NB, May 15, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF - News) (the "Company" or "Organigram"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, is pleased to announce that Health Canada has issued the Company a License for Controlled Drugs and Substances ("Dealer's License") making Organigram a "Licensed Dealer".

  • Baystreet2 months ago

    Stocks in play: Organigram Holdings Inc.

    Has entered a non-binding term sheet to acquire up to 25% of alpha-cannabis Pharma GmbH located in Stadthagen, ...

  • CNW Group2 months ago

    Organigram Announces First International Expansion Investment

    MONCTON, NB, May 8, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQB:OGRMF - News) (the "Company" or "Organigram"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, is pleased to announce it has entered a non-binding term sheet to acquire up to 25 per cent of alpha-cannabis Pharma GmbH ("Alpha-Cannabis Germany" or "ACG") located in Stadthagen, Germany.

  • CNW Group3 months ago

    Organigram Announces Record Q2 Financial Results - Net Income of $1.1 Million

    Record Net Sales of $3.7 Million for the Quarter and Earnings Per Share (Basic) of $0.009 MONCTON, NB , April 24, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQB:OGRMF) (the " Company ...

  • CNW Group3 months ago

    Organigram Begins First Harvests From New Grow Rooms

    MONCTON, NB, April 23, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF - News) (the "Company" or "Organigram"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, is pleased to announce the yield results from the inaugural harvest in the first of its 23 new, state-of-the-art Phase 2 indoor grow rooms. Beginning on Friday, "4/20" and completed on Saturday, Organigram harvested over 1500 plants from the first room commissioned in the Company's Phase 2 expansion. Initial yields support the Company's predictions that changes in process efficiencies will result in annual yields higher than initially estimated when Phase 2 was designed.  At present, the Company reaffirms its target production capacity from Phases 1 and 2 of approximately 22,000 kg/year (up from initial estimations of 16,000 kg/year).

  • Cannabis Growth Opportunity Corporation announces investment in US based cannabis company Jushi Inc.
    CNW Group3 months ago

    Cannabis Growth Opportunity Corporation announces investment in US based cannabis company Jushi Inc.

    TORONTO , April 17, 2018 /CNW/ - Cannabis Growth Opportunity Corporation (the "Corporation") (CSE: CGOC) a cannabis focused investment corporation with both public and private cannabis holdings, ...

  • CNW Group3 months ago

    Organigram to Attend and Present at 2018 GMP Securities Cannabis Conference

    TORONTO, April 16, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF - News) (the "Company" or "Organigram"), is pleased to share details on the Company's involvement at the GMP Securities' 2018 Cannabis Conference on April 19, 2018 at the Ritz-Carlton Hotel in Toronto. Organigram Chief Executive Officer Greg Engel will provide a Company update including updates for the Organigram facility as well as details on the Company's domestic and international expansion plans in the second-floor ballroom of the Ritz-Carlton Hotel from 9:20 a.m. to 9:40 a.m. on April 19.

  • ACCESSWIRE3 months ago

    Research Reports on Aurinia Pharma, Immunovaccine, IntelliPharmaCeutics International, and OrganiGram Holdings

    LONDON, UK / ACCESSWIRE / April 12, 2018 / Active-Investors free stock reports for this morning include these Toronto Exchanges' equities from the Biotechnology industry: Aurinia Pharmaceuticals, Immunovaccine, ...

  • CNW Group4 months ago

    Organigram Announces Director Resignation

    Denis Arsenault completes objectives as Organigram board member MONCTON, NB , March 29, 2018 /CNW/ – Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF) (the " Company " or " Organigram ...

  • CNW Group5 months ago

    Organigram appoints Guillermo Delmonte as President of new international division, sets ambitious plan for international expansion

    MONCTON, NB, March 7, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF - News) (the "Company" or "Organigram"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, is pleased to announce the appointment of Guillermo Delmonte as the President, of its new international division.  Mr. Delmonte will assume his new role effective March 8, 2017. A proven leader in the international cannabis and CBD marketplace, Mr. Delmonte joins the Organigram team following two and a half years as Chief Executive Officer at ICC Labs Inc., a leading international hemp and cannabis producer.